Cite
Regadenoson Stress Perfusion Cardiac Magnetic Resonance Imaging in Children With Kawasaki Disease and Coronary Artery Disease.
MLA
Doan, Tam T., et al. “Regadenoson Stress Perfusion Cardiac Magnetic Resonance Imaging in Children With Kawasaki Disease and Coronary Artery Disease.” The American Journal of Cardiology, vol. 124, no. 7, Oct. 2019, pp. 1125–32. EBSCOhost, https://doi.org/10.1016/j.amjcard.2019.06.033.
APA
Doan, T. T., Wilkinson, J. C., Loar, R. W., Pednekar, A. S., Masand, P. M., & Noel, C. V. (2019). Regadenoson Stress Perfusion Cardiac Magnetic Resonance Imaging in Children With Kawasaki Disease and Coronary Artery Disease. The American Journal of Cardiology, 124(7), 1125–1132. https://doi.org/10.1016/j.amjcard.2019.06.033
Chicago
Doan, Tam T, James C Wilkinson, Robert W Loar, Amol S Pednekar, Prakash M Masand, and Cory V Noel. 2019. “Regadenoson Stress Perfusion Cardiac Magnetic Resonance Imaging in Children With Kawasaki Disease and Coronary Artery Disease.” The American Journal of Cardiology 124 (7): 1125–32. doi:10.1016/j.amjcard.2019.06.033.